Synonyms: Example 6 [WO2014169843]
Compound class:
Synthetic organic
Comment: The chemical structure for luvometinib was obtained from WHO proposed INN list 131 (August 2024). The INN document records luvometinib as a mitogen-activated protein kinase (MEK) inhibitor and antineoplastic agent. It is one of the compounds claimed in patent WO2014169843A1 (Fochon Pharmaceutical) [3]. Fochon Pharmaceutical have one MEK inhibitor in their declared development pipeline, FCN-159. Published information about FCN-159 indicates that it is an orally available MEK1/2 inhibitor lead for the treament of BRAF- or RAS-driven tumours [1-2]. Inhibition of MEK1/2 disrupts downstream MAPK signalling that is activated by upstream mutant RAF/RAS enzymes in malignancies.
|
|
Download 2D Structure ![]() |
|
Canonical SMILES | Download |
Isomeric SMILES | Download |
InChI standard identifier | Download |
InChI standard key | Download |
Molecular structure representations generated using Open Babel